title: [Prognostic factors of efficacy of eradication therapy in patients with duodenal ulcer].
abstract: The aim of the study was to determine microorganism-associated predictors of efficacy of eradication therapy in patients with Helicobacter pylori-associated duodenal ulcer. The subjects were 129 such patients. Clinical, endoscopic, microbiological, and immunological examination revealed differences in the initial immune status, the structure of gastroduodenal zone mucosa, and large bowel biocenosis, which predict efficacy of eradication therapy.
authors.forename: I V
authors.initials: IV
authors.lastname: Kozlova
authors.forename: Iu Iu
authors.initials: IuIu
authors.lastname: Eliseev
authors.forename: A L
authors.initials: AL
authors.lastname: Pakhomova
authors.forename: Sadzhad Akhmad
authors.initials: SA
authors.lastname: Khan
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D000907:Antibodies, Bacterial / Q000276:immunology; D001323:Autoantibodies / Q000097:blood; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D004384:Duodenoscopy; D005500:Follow-Up Studies; D016481:Helicobacter Infections / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D016480:Helicobacter pylori / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D007136:Immunoglobulins / Q000097:blood; D007413:Intestinal Mucosa / Q000382:microbiology / Q000473:pathology; D012189:Retrospective Studies; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D000907:Antibodies, Bacterial; D001323:Autoantibodies; D007136:Immunoglobulins